Results 231 to 240 of about 254,717 (266)
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source
A case series of hyperthermia crisis in cough mixture ingestion: Why early cooling save lives. [PDF]
Chun H, Chow TYA.
europepmc +1 more source
Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung +17 more
wiley +1 more source
A framework for governing Canada's tobacco settlement funds. [PDF]
Eisenkraft Klein D.
europepmc +1 more source
Deus Ex Machina: An Ethnographic Exploration of Technology, Death and Decision-Making in Respiratory Care. [PDF]
Wenzel D +4 more
europepmc +1 more source
Expanding Pharmacists' Prescribing Authority and Medication Uptake: Evidence From Pre-Exposure Prophylaxis. [PDF]
Fayaz-Farkhad B.
europepmc +1 more source

